PRESS RELEASE
News
-
-
PRESS RELEASE
HotelRunner Joins MarketHub Europe by HBX Group as Platinum Sponsor
HotelRunner, a leading hospitality and travel technologies platform, to participate as Platinum Sponsor at MarketHub Europe by HBX Group. Event to explore 'New Frontiers' in travel industry from June 25-28, 2024, in Istanbul -
PRESS RELEASE
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
FSD Pharma Inc. enters into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization, potentially enhancing unbuzzd™ effectiveness and expanding target markets with novel products -
PRESS RELEASE
Northern Superior Details Philibert Exploration Strategy Including Connecting Mineralization 1.5 KM Southeast of Current Resource
Northern Superior Resources Inc. unveils exploration plan for Philibert gold property in Québec, Canada. Program includes 20,000m of expansion drilling and focuses on potential mineralization extensions -
PRESS RELEASE
Chow Tai Fook Jewellery Celebrates 95th Anniversary with Record High Revenue and Core Operating Profit for FY2024
Chow Tai Fook Jewellery Group announces FY2024 annual results. Revenue increased 14.8%, core operating profit rose 28.9%, and positive momentum from brand transformation. Details of financial performance and strategic priorities discussed -
-
-
-
PRESS RELEASE
Safe Exchange and Pixalate Come Together to Ensure Programmatic Ad Decisioning Better Serves Global Audiences
Safe Exchange™ partners with Pixalate to enhance ad fraud protection and compliance analytics for improved programmatic ad decision-making. APMC and Pixalate collaboration aims to elevate trust and transparency in CTV advertising -
PRESS RELEASE
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
Moderna's mRNA-1283 demonstrates non-inferior COVID-19 vaccine efficacy compared to Spikevax in Phase 3 trial. Higher efficacy in adults observed. Positive interim results reported
